Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 19, 2010, Pages 5757-5762

  Mendgen, Thomas ^a   Scholz, Therese ^a   Klein, Christian D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

MurA; Peptidoglycan; Tulipalines; Tuliposides

Indexed keywords

CNICIN; FOSFOMYCIN; NATURAL PRODUCT; TRANSFERASE; TULIPALINE A; TULIPALINE B; TULIPOSIDE A; TULIPOSIDE B; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE 1 CARBOXYVINYLTRANSFERASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ESCHERICHIA COLI; GROWTH INHIBITION; IC 50; NONHUMAN; STRUCTURE ACTIVITY RELATION;

4-BUTYROLACTONE; ALKYL AND ARYL TRANSFERASES; ANTI-BACTERIAL AGENTS; ENZYME INHIBITORS; SODIUM OXYBATE; STRUCTURE-ACTIVITY RELATIONSHIP; TULIPA;

EID: 77957579305     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.07.139     Document Type: Article

References (20)

1. S. Eschenburg, W. Kabsch, M.L. Healy, and E. Schonbrunn J. Biol. Chem. 278 2003 49215
2. E. Schonbrunn, S. Sack, S. Eschenburg, A. Perrakis, F. Krekel, N. Amrhein, and E. Mandelkow Structure 4 1996 1065
3. T. Skarzynski, A. Mistry, A. Wonacott, S.E. Hutchinson, V.A. Kelly, and K. Duncan Structure 4 1996 1465
4. A. Bachelier, R. Mayer, and C.D. Klein Bioorg. Med. Chem. Lett. 16 2006 5605
5. A. Steinbach, A.J. Scheidig, and C.D. Klein J. Med. Chem. 51 2008 5143
6. R. Tschesche, F.J. Kämmerer, G. Wulff, and F. Schönbeck Tetrahedron Lett. 9 1968 701
7. P. Barbier, and C. Benezra J. Med. Chem. 29 1986 868
8. C. Benezra Acta Derm. Venereol. Suppl. (Stockh.) 134 1987 62
9. L.P. Christensen Contact Dermatitis 41 1999 320
10. C. Papageorgiou, J.L. Stampf, and C. Benezra Arch. Dermatol. Res. 280 1988 5
11. K. Shigetomi, K. Shoji, S. Mitsuhashi, and M. Ubukata Phytochemistry 71 2010 312
12. P.A. Lanzetta, L.J. Alvarez, P.S. Reinach, and O.A. Candia Anal. Biochem. 100 1979 95
13. 4 was utilized as a standard.
14. D. Basavaiah, A.J. Rao, and T. Satyanarayana Chem. Rev. 103 2003 811
15. H.S. Byun, K.C. Reddy, and R. Bittman Tetrahedron Lett. 35 1994 1371
16. A. Bernardi, M.G. Beretta, L. Colombo, C. Gennari, G. Poli, and C. Scolastico J. Org. Chem. 50 1985 4442
17. R.S. Porto, and F. Coelho Synth. Commun. 34 2004 3037
18. Ö. Elisabeth, R. Klaus, and S. Ulrich Angew. Chem. 82 1970 480
19. J.A. Stubbe, and G.L. Kenyon Biochemistry 11 1972 338
20. Screening for antimicrobial activities was performed by monitoring the optical density (OD) at 590 nm using 96-well U-bottom polystyrene microtiter plates. Bacterial cells from an overnight culture of E. coli BL21(DE3) grown in LB- or minimal medium were diluted 50-fold with the respective medium, resulting in an OD (590 nm) of 0.03. 245 μl of the dilution were dispensed into the wells containing 5 μl of test solutions prepared in DMSO, giving a final concentration of the test compounds of 200 μM. Control wells were prepared with fosfomycin. Plates were incubated at 37 °C for 7 h. Bacterial growth was measured as increase in OD 590 nm. Antimicrobial activity (growth inhibition, GI) was calculated as the OD percentage relative to an uninhibited control.